
Granules India Limited has informed the Exchange about press release dated 26-Aug-2022 titled Granules India Limited Received ANDA Approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets
Filed with NSE ·

Granules India Limited has informed the Exchange about press release dated 26-Aug-2022 titled Granules India Limited Received ANDA Approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India